Psychosomatic Medicine Tips for Better Browsing
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Martin, A.
Right arrow Articles by Jacobi, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Martin, A.
Right arrow Articles by Jacobi, F.
Related Collections
Right arrow Somatoform
Right arrow Other Psychiatric Disorders
Psychosomatic Medicine 68:770-777 (2006)
© 2006 American Psychosomatic Society


ORIGINAL ARTICLES

Features of Hypochondriasis and Illness Worry in the General Population in Germany

Alexandra Martin, PhD and Frank Jacobi, PhD

From the Section for Clinical Psychology and Psychotherapy, Philipps-University of Marburg, Marburg, Germany (A.M.); and the Institute of Clinical Psychology and Psychotherapy, Technische Universität Dresden, Dresden, Germany (F.J.).

Address correspondence and reprint requests to Alexandra Martin, PhD, Philipps-University, Section for Clinical Psychology and Psychotherapy, Gutenbergstr. 18, D-35032 Marburg, Germany. E-mail: martin{at}staff.uni-marburg.de


    ABSTRACT
 TOP
 ABSTRACT
 INTRODUCTION
 METHOD
 RESULTS
 DISCUSSION
 Appendix 1
 NOTES
 REFERENCES
 
Objective: Although hypochondriasis is considered to be of high relevance in the healthcare sector, its prevalence in the general population has been investigated in few studies. The aims of this study were to estimate prevalence rates of hypochondriasis and of subthreshold conditions and to describe their associated features such as quality of life and healthcare utilization in a representative community sample.

Methods: Analyses of the present study are based on the German Health Interview and Examination Survey–Mental Health Supplement (N = 4181, representative for the German population from 18–65 years). The assessment included interviews for somatic conditions and mental disorders and self-report ratings on health-related quality of life, healthcare utilization, disability days, and physical activity.

Results: Only three cases (0.05%) were identified as meeting full criteria of Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) hypochondriasis. The prevalence rate of the less restrictively defined form of hypochondriasis, ("subthreshold hypochondriasis") was 0.58% and an additional 2.12% reported having had illness worries for at least 6 months but did not meet further hypochondriasis criteria. The two subthreshold diagnostic groups provided strong evidence of difference from the nonhypochondriac controls: comorbidity with psychiatric and medical disorders and healthcare utilization were higher, and quality of life was markedly reduced.

Conclusions: The results provide additional support to not only consider "full" DSM-IV hypochondriasis, which is a very rare disorder in the general population, but also to include less restrictive hypochondriac conditions—associated with a clinically relevant degree of psychological and physical impairment—into clinical and scientific considerations.

Key Words: hypochondriasis • illness worry • epidemiology • psychiatric disorders • somatoform • DSM-IV

Abbreviations: DSM-IV = Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition; GHS = The German National Health Interview and Examination Survey; GHS-CS = core survey; GHS-MHS = mental health supplement; H0 = no illness worry group; H1 = unrealistic illness worry group; H2 = subthreshold hypochondriasis; M-CIDI = Munich Composite International Diagnostic Interview.


    INTRODUCTION
 TOP
 ABSTRACT
 INTRODUCTION
 METHOD
 RESULTS
 DISCUSSION
 Appendix 1
 NOTES
 REFERENCES
 
The core feature of hypochondriasis according to the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) is preoccupation with fears of, or the idea that one has, a serious disease based on a misinterpretation of bodily symptoms (criterion A). Another criterion is the persistence of this preoccupation despite appropriate medical evaluation and reassurance (criterion B). These symptoms cause clinically significant distress or impairment in important areas of functioning (criterion D) and last for at least 6 months (criterion E). Hypochondriasis is grouped with the somatoform disorders, which share the general feature of symptoms that cannot be fully explained by a general medical condition, although a coexisting general medical condition may be present. Hypochondriasis in International Classification of Diseases, 10th Revision (ICD-10) is based on comparable diagnostic criteria (1,2).

Hypochondriasis is a highly disabling condition. Patients with hypochondriasis were found to view their health as worse than and to exhibit more severe psychiatric symptoms than age- and sex-matched control subjects (3). The association between health-related anxiety and higher medical care utilization persists even after adjusting for differences in sociodemographic characteristics and medical morbidity (4).

Relatively little is known about the epidemiology of hypochondriasis, especially in the general population. The few population-based studies using interviews consistently reveal no or only very few hypochondriasis cases (5–7). Only studies based on less restrictive inclusion criteria or studies using self-report questionnaires revealed higher case numbers. These prevalence rates varied from 4% to 10% in population-based samples (6,8,9).

Hypochondriasis has been investigated more often in medical patients. In general medical practice, the prevalence of hypochondriasis varied between 0.8% and 9% (10–12), and a median prevalence of 4.2% in seven primary care samples has been reported (13). Most of these studies indicate that hypochondriac concerns appear quite often in medical settings. However, clinical samples may be influenced by selection bias. Thus, estimates of prevalence still vary as a result of the definition of hypochondriasis, instruments, and sample characteristics.

It has been questioned whether to classify hypochondriasis as a discrete diagnostic entity. Some conceptualize hypochondriasis dimensional rather than as a category, underlying many different mental as well as physical conditions. The current DSM-IV hypochondriasis diagnosis has been questioned because it does not satisfy either clinical or nosologic validity requirements (14). Gureje and colleagues (10) have criticized the current definition of hypochondriasis as too restrictive for use. They outline the relevance of "abridged hypochondriasis" consisting of the triad of illness worry associated with distress or interference with functioning and medical help-seeking (ICD-10 F.45.2, criteria A and B). The full criteria of hypochondriasis, including the criterion that patients refuse to accept medical reassurance that symptoms had no physical causation, were identified only in 0.8% of cases in primary care (in 41 of 5447 patients across 14 countries); the prevalence of "abridged hypochondriasis" was 2.2%. Patients with abridged hypochondriasis were different from nonhypochondriac patients but highly similar to patients meeting the full ICD-10 criteria. Looper and Kirmayer (6) have also investigated the concept of the previously mentioned "abridged hypochondriasis" as well as the even broader concept of illness worry (Composite International Diagnostic Interview [CIDI] probe question for hypochondriasis) in a community population. They found a rate of 1.3% for abridged hypochondriasis, which is lower than in primary care. However, 6.2% of the sample reported illness worry during a period of 6 months, and illness worry was an independent predictor of increased levels of distress and of healthcare utilization.

Given the fact that there is a lack of surveys to assess hypochondriasis in the adult general population based on clinical diagnostic interviews, the first aim of the present study was to estimate 12-month prevalence rates of DSM-IV hypochondriasis and of subthreshold hypochondriac conditions in the general population.

The second target of this study was to investigate external validity of the criteria used to define hypochondriasis in DSM-IV. This question was addressed with the comparison of three diagnostic groups fulfilling criteria of hypochondriasis to different degrees—"subthreshold hypochondriasis," "unrealistic illness worry," and "no illness worry"—with regard to some relevant indicators such as physical and mental health, quality of life, and healthcare utilization.


    METHOD
 TOP
 ABSTRACT
 INTRODUCTION
 METHOD
 RESULTS
 DISCUSSION
 Appendix 1
 NOTES
 REFERENCES
 
Design and Sample
The German National Health Interview and Examination Survey (GHS) was designed to provide representative nationwide epidemiologic data on major somatic and mental disorders, impairments, and healthcare utilization. It is based on a two-stage modular design and consisted of 1) the core survey (GHS-CS, N = 7124) and 2) the mental health supplement (GHS-MHS, N = 4181). The GHS-CS sample was drawn from the population registries of subjects aged 18 to 79 living in Germany in 1997 (stratified random sample from 113 communities throughout Germany with 130 sampling units, response rate: 61.4%). The subsample of the GHS-MHS (conditional response rate: 87.6% from N = 4775 eligible subjects) was restricted to respondents up to 65 years because the psychometric properties of the diagnostic interview (M-CIDI) have not been established for use in older populations (15). The study was commissioned by the German Ministry of Research, Education and Science (BMBF) and approved by the relevant Institutional Review Board and ethics committee. Written informed consent was obtained for both surveys. Subjects did not get any financial compensation for their study participation. Field work was done between November 1997 and April 1999. Comprehensive information about design and sample of the GHS is provided elsewhere (16,17).

Assessment
Hypochondriasis/Mental Disorders
Psychiatric diagnoses were assessed by the computer-assisted version of the Munich Composite International Diagnostic Interview (DIA-X/M-CIDI) (18). This fully structured interview is a modified version of the World Health Organization CIDI, version 1.2 (19) supplemented by questions to cover DSM-IV criteria of mental disorders. Psychometric properties and feasibility of the CIDI somatoform section are regarded as good (20). Interviews were conducted at the respondent’s homes by clinically trained interviewers (psychologists and MDs) because the use of lay interviewers has been discussed as a limitation of CIDI studies in the past. The following diagnostic groups were defined with increasing fulfillment of DSM-IV criteria of hypochondriasis (for the detailed coding algorithm, see the Appendix):

No illness worry (H0): The stem question on hypochondriasis was answered negatively; any other mental disorder or physical condition could be present.
Unrealistic illness worry (H1): Illness worries were reported with duration of at least 6 months within the last 12 months without evidence of the medical condition the subject was worrying about.
Subthreshold hypochondriasis (H2): In addition to illness worries, subjects reported clinically significant distress or impairment in important areas of functioning as a result of their preoccupation of having a serious disease.
Hypochondriasis: The diagnosis of hypochondriasis is additionally based on the persistence of the preoccupation despite appropriate medical evaluation and reassurance.

Given the low rates of threshold DSM-IV-hypochondriasis in the general population sample, further analyses only included comparisons among the groups "no illness worries" (H0), "unrealistic illness worry" (H1), and "subthreshold hypochondriasis" (H2). The subjects fulfilling all criteria of hypochondriasis were included in the group "subthreshold hypochondriasis."

Somatic Conditions
A structured computer-assisted clinical medical interview (CAPI) was conducted by study doctors to assess the presence of a wide range of acute and chronic somatic conditions (e.g., cardiac diseases, ulcers, gastritis, diabetes, cancer, neurologic diseases, musculoskeletal diseases, allergies). In this interview, stem questions ("Were you ever assigned the diagnosis of ... by a physician?") were supplemented by additional disease-specific probe questions (16).

Health-Related Quality of Life
The German version of the 36-Item Short Form Health Survey SF-36 (21,22) is a multidimensional questionnaire measuring health-related quality of life based on the World Health Organization definition of health. The SF-36 includes eight subscales (ranging from 2–10 items): general health, physical functioning, bodily pain, vitality, mental health, social functioning, physical role limitation, emotional role limitation. Subscale scores were transformed into a 0 to 100 scale, higher scores representing better health.

Health Service Utilization and Illness Behavior
Subjects were asked to indicate whether they had seen medical specialists from a list of 18 doctor subspecialties during the previous 12 months and, if so, how often they had consulted them. The total number of healthcare visits during the past 12 months was counted as an indicator of healthcare utilization. All subjects were asked to report the number of disability days (not being able to carry out usual activities as a result of feeling sick) during the past 12-month period. In addition, subjects were asked to indicate the number of hours per week spent on physical/sporting activity (considering the previous 3 months); based on these data, the number of subjects with less than 1 weekly hour of physical activity was calculated.

General Sociodemographic Information
Data on age, marital status, education, income, and work situation were collected by questionnaire. The "index of social class" was derived from information on educational level, income, and current job position (23).

Statistical Analyses
Prevalence estimates were weighted according to the sampling scheme and to adjust the net sample to age, sex, and community distributions in Germany (corresponding to the national administrative statistics of December 1997). The mental health supplement sample was considered to provide a good to almost perfect representation of the German population in terms of the selected biosocial variables (16). Calculations of 12-month prevalence rates and 95% confidence intervals were performed using the Stata software package, version 7.0 (24).

Further analyses were based on nonweighted data. Thus, all subjects fulfilling the previously mentioned criteria were included, and group sizes differed slightly from weighted data. To assess differences between the three diagnostic groups, mean scores of criteria variables were compared by the WELCH test (asymptotic F distribution) (25). This procedure is comparable to analysis of variances but takes into account that population variances differ significantly, and testing is more conservative (26). If the overall group effect was significant, multiple paired post hoc comparisons of groups were computed with the test of GAMES-HOWELL to control for the probability of increasing type I error. This test does not need homogeneity of variances and is recommended in cases of unequal sample sizes (27,28). Effect sizes (Cohen’s d) of the paired comparisons were computed. Health-related quality of life was assessed with the eight subscales of the SF-36. To reduce risk of type I error, group differences were first analyzed with multivariate analysis of variances as a global test. All analyses on group differences were conducted with SPSS statistical package (version 12.0).


    RESULTS
 TOP
 ABSTRACT
 INTRODUCTION
 METHOD
 RESULTS
 DISCUSSION
 Appendix 1
 NOTES
 REFERENCES
 
Prevalence of DSM-IV Hypochondriasis and Subthreshold Syndromes
Among the 4181 subjects of GHS-MHS, only three (weighted: two) cases were identified as meeting the full criteria of DSM-VI hypochondriasis. The estimated weighted 12-month prevalence rate was 0.05%, suggesting that hypochondria is very rare in the general population (Table 1). A total of 30 cases (weighted: 24; 12-month prevalence: 0.58%) met criteria of a subthreshold hypochondriasis disorder as defined here. In addition, a total of 101 subjects (weighted: 88; 12-month prevalence: 2.12%) were identified as reporting unrealistic illness worries for a period of at least 6 months, but did not fulfill the CIDI impairment criterion. In the other screen-positives (N = 349, N weighted = 320), the reported illness worries were a) considered not to be severe enough, b) related either to a diagnosed medical condition or exclusively to medication/drugs, or c) the clinical judgment on severity or adequacy of the illness worries was missing.


View this table:
[in this window]
[in a new window]
 
TABLE 1. 12-Month Prevalence Rates of Hypochondriasis and Subthreshold Syndromes in the General Population (GHS-MHS, N = 4181)

 

Comparison of Diagnostic Groups
The subjects were assigned to three different groups according to the degree of criteria fulfilled for DSM-IV hypochondriasis. The three study groups "subthreshold hypochondriasis" (N = 33, including the three threshold cases), "unrealistic illness worry" (N = 101, with subthreshold hypochondriasis not included), and the control group "no illness worry" (N = 3698) were compared on sociodemographic variables, medical and psychiatric conditions, psychological variables, and healthcare utilization.

Sociodemographic Variables
In the subthreshold hypochondriasis group, 63.4% were women; in the illness worry group, 52.5% were women; and in controls with no illness worries, 53.9% were women (not significant; Table 2). Subjects experiencing illness worries were significantly older than controls (mean age, 45.2 versus 41.5 years), whereas subjects in the subthreshold group were not. Being single was more frequent in control subjects (25.2% versus 12.1/14.3%). The groups did not differ with respect to their subjects’ socioeconomic status (index of social class).


View this table:
[in this window]
[in a new window]
 
TABLE 2. Sociodemographic Characteristics and Comorbidity With Physical and Psychiatric Conditions by Diagnostic Groups (and statistics)

 

Physical and Psychiatric Comorbidity
The rate of subjects with at least one physical condition during the last 12 months was generally high in all groups (Table 2). At least one physical diagnosis was assigned to 69.4% of the controls (H0), and even more subjects in the two hypochondriasis groups were affected by at least one physical condition (90.9% in H2, 87.1% in H1; these physical conditions were not rated as explaining the subjects’ illness worry). The number of additional physical conditions was highest in subthreshold hypochondriac subjects followed by subjects with unrealistic illness worry and lowest in controls without illness worry.

The base rate of having any mental disorder in the total sample was 31.1% (29). Most of the subjects in H2 and H1 met the DSM-IV criteria of at least one mental disorder (81.8% in "subthreshold hypochondriasis," 74.3% in "illness worry" group), whereas subjects without illness worries (H0) were not affected to the same degree by any mental disorder (30.6%). Likewise, the average number of comorbid mental disorders was highest in "subthreshold hypochondriasis" (mean, 3.3) followed by the "illness worry group" (mean, 1.8) and lowest in control subjects (mean, 0.5).

Health-Related Quality of Life
Table 3 presents the mean scores of the SF-36 dimensions, which cover different aspects of health-related quality of life. First, a multivariate analysis of variance was computed. The overall effect of the group factor on all eight subscales was highly significant ({lambda} = 0.93, F(16,7350) = 16.4; p < .001). Both illness worry groups perceived all included aspects of health-related quality of life significantly worse than control subjects without illness worries. "Subthreshold hypochondriasis" and "unrealistic illness worry" groups differed in five subscales (reduced quality of life in the "subthreshold hypochondriasis" group with regard to physical role functioning, general health, vitality, emotional role functioning, and mental health).


View this table:
[in this window]
[in a new window]
 
TABLE 3. Quality of Life: Mean Scores of SF-36 (range, 0–100; higher scores representing better health) by Diagnostic Groups (and statistics)

 

Healthcare Utilization and Illness Behavior
The number of healthcare visits during the previous 12 months served as an indicator of healthcare utilization (Table 4). The mean overall number of healthcare visits was almost twice as high in the illness worry groups (in H2: mean, 20; in H1: mean, 18) than in control subjects without illness worry (mean, 10). Accordingly, results of the paired comparisons showed the number of doctor visits to be significantly higher in both illness worry groups than in control subjects; healthcare utilization did not differ significantly between subthreshold hypochondriasis and unrealistic illness worry group.


View this table:
[in this window]
[in a new window]
 
TABLE 4. Healthcare Utilization and Illness Behavior: Mean Scores by Diagnostic Groups (and statistics)

 

Most of the healthcare visits were dedicated to general medical doctors in all groups, and only a few consultations with psychiatrists and psychotherapists were reported. The average number of mental health visits did not vary between the diagnostic groups. However, with regard to the proportion of subjects consulting a mental health professional at least once during the previous year, a slightly different picture emerged: 28.1% of the "subthreshold hypochondriasis" group and 18.8% of the "unrealistic illness worry" group had seen a psychiatrist or psychotherapist at least once during the previous year. At a significantly lower rate, subjects in the "no illness worry" group (7.6%) consulted mental health professionals.

The total number of disability days during the previous 12 months was higher in the "subthreshold hypochondriasis" (mean, 57.3) and "unrealistic illness worry" (mean, 29.3) groups compared with control subjects (mean, 11.4); the comparison between the "subthreshold hypochondriasis" and "unrealistic illness worry" groups was not significant.

Physical activity was another aspect of illness behavior investigated in this survey. Approximately 75% of subjects in the two hypochondriasis groups reported less than 1 hour weekly spent on physical activity, whereas the proportion of physically inactive subjects was smaller in the control group (60%).

Reanalysis to Control for Physical Comorbidity and Age
In a second step, a reanalysis of the main variables was conducted controlling for the number of comorbid physical diagnoses and for age (ANCOVAs). Although the effects of the covariates were significant, the group differences for healthcare utilization, disability days, and health-related quality of life were still highly significant. Thus, the identified group differences in these features cannot be solely explained by the differences in somatic health status or age.

Reanalysis to Control for Potential Influence of the Hypochondriasis Cases
Because of the small number of hypochondriasis cases, the data of the three cases were analyzed together with the 30 subthreshold hypochondriasis cases in comparison of the diagnostic groups. To rule out a possible bias resulting from these cases, we reanalyzed the data without the hypochondriasis cases, showing the same result pattern as described. In addition, descriptive data of the three hypochondriasis cases suggest mean values to be comparable to subthreshold cases.


    DISCUSSION
 TOP
 ABSTRACT
 INTRODUCTION
 METHOD
 RESULTS
 DISCUSSION
 Appendix 1
 NOTES
 REFERENCES
 
The present study assessed the prevalence of hypochondriasis in a general population sample and investigated associated features with hypochondriac subgroups, which were defined by gradual inclusion of DSM-IV criteria of hypochondriasis.

Prevalence in the General Population
The GHS-MHS was the first representative nationwide mental health survey in Germany covering somatic and mental disorders simultaneously within one study. Threshold hypochondriasis was found to be very rare: only three (weighted: two) of 4181 subjects were identified, resulting in a 12-month prevalence estimate of 0.05%. This result confirms prior findings that hypochondriasis according to its classification in DSM-IV and ICD-10 is extremely rare in the general population as well as in primary care surveys (6,10).

It has been argued to define hypochondriasis by using less restrictive criteria, because the estimated prevalence in subthreshold conditions such as "abridged hypochondriasis" might depict the clinical reality of the disorder more appropriately (10). Following this approach, we defined a subthreshold group of hypochondriasis by omitting the criterion B of DSM-IV ("the preoccupation persists despite appropriate medical evaluation and reassurance"), which might be a less reliable criterion. This condition was characterized by hypochondriac illness worries lasting for at least 6 months and the preoccupation resulting in clinically significant distress or impairment in important areas of functioning. The weighted 12-month prevalence rate of subthreshold hypochondriasis was 0.58%. As expected, this is still a lower rate than in primary care. Furthermore, an additional 2.12% of the subjects reported persistent illness worries without evidence of the conditions the subjects were worrying about.

Although psychometric properties and feasibility of the somatoform section of the standardized CIDI have been proven acceptable at least in clinical populations (20), one could question whether such an interview-based survey can properly assess the phenomenon of hypochondriasis. Affected subjects are probably willing to report illness worries but might be less likely to disclose their difficulties to accept medical reassurance and the severity of the problem, leading to low prevalence rates for hypochondriasis.

Because of the low number of cases with full hypochondriasis, it was not possible to compare this group directly with subthreshold conditions. It is therefore difficult to draw any conclusion about the relevance of this group. Instead, we considered three diagnostic groups ("subthreshold hypochondriasis," "unrealistic illness worry," and "no illness worry").

The two hypochondriac groups did not differ from nonhypochondriac subjects with respect to most sociodemographic variables. Women did not appear to be affected more often by hypochondriac conditions than men. Comparably, Creed and Barsky (13) identified only one of 11 studies that showed a significant association with female sex. Subjects experiencing illness worries were slightly older than control subjects, but subjects with the more severe form of subthreshold hypochondriasis were not older than the two other groups. The majority of previous population-based studies (eight of 11 studies) did not report a significant association between hypochondriasis and older age (13). On the other hand, general health anxiety increases probably with age as physical problems do as well (9).

Comparisons Between Hypochondriac Groups and Control Subjects
In all included health-related variables, the two hypochondriac groups differed from the nonhypochondriac control subjects: comorbidity with mental disorders and medical conditions were higher, health-related quality of life was markedly reduced (in all SF-36 dimensions), and healthcare utilization and illness behavior (disability days, lack of physical activity) were exceeding the one of control subjects. The effect sizes of paired group comparisons were medium to large.

Subjects with subthreshold hypochondriasis as well as those with unrealistic illness worries reported almost twice the number of healthcare visits in the previous year than control subjects. It has to be considered that the data on healthcare utilization were based on self-report, and assessment through medical or health insurance record review would be preferable but was not possible within the limits of a representative population survey. Still, the positive significant relationship between self-reported and dossier data on doctor visits has been reported previously (30). Furthermore, the result of this study is compatible with many previous findings of an association between hypochondriasis and somatization with increased outpatient utilization (4,31,32). The results on higher rates of general doctor visits in subthreshold hypochondriasis and the unrealistic illness worry group persisted even if controlled for higher physical morbidity and age. Thus, the degree of illness worry and hypochondriac preoccupation seem to be important in addition to possibly existing somatic conditions. This confirms prior findings of higher physical comorbidity being associated with illness worry but illness worry contributing to increased levels of healthcare utilization as an independent factor (6,7). Of course, our cross-sectional assessment does not allow answering the question of causality.

Compared with attendance rates in general medical care, psychotherapists or psychiatrists were rarely consulted. Although the number of subjects reporting at least one mental healthcare visit was higher in both hypochondriac subgroups than in control subjects, the mean number of visits at psychotherapists and psychiatrists was low, and as a result of these low rates and variability, no significant differences between groups were found. Against the background of considerable psychiatric comorbidity, this is especially striking in hypochondriac groups and suggests once more that people with fears of having a physical disease prefer to consult general medical services rather than mental health professionals. The low mental health consultation rates may also result from not being referred to mental health services, because these problems often lack recognition in general medical settings (33).

With regard to all these clinical features, the results indicate increased levels of impairment not only in the group of subthreshold hypochondriasis, but already in the group characterized by persistent illness worries. Comparing subthreshold hypochondriasis with the unrealistic illness worry group demonstrates more severe disability in the former group. In the group with subthreshold hypochondriasis, comorbidity with physical and mental disorders was highest and quality of life lowest in some important areas (physical and emotional role functioning, perception of the general and mental health and vitality). Interestingly, the two hypochondriac groups did not differ with respect to their healthcare utilization and the other aspects of illness behavior. These results confirm findings from studies using abridged hypochondriasis or significant illness worry definitions for hypochondriasis (6,10).

Definition of Hypochondriasis and the Criterion of Reassurance
Most definitions of hypochondriasis include "the persistent preoccupation with illness worry or conviction" as a core criterion. The criterion of "reassurance" has been frequently criticized. Gureje and colleagues (10) argued that the ICD-10 criterion "persistent refusal to accept medical reassurance" might constitute a "bottleneck" in the diagnosis of hypochondriasis, because it has a disproportionate effect on prevalence. Others criticized its current conceptualization in DSM-IV because a precise definition on the "appropriateness" of medical reassurance is not provided. Patients with hypochondriasis are generally regarded as resistant to routine, ordinarily given medical reassurance, but not necessarily to types of reassurance that are more adapted to the particular situation of the hypochondriac subject (34). There also might be physicians who do not provide an appropriate and effective reassurance for patients with hypochondriac concerns or people consider not being reassured the same as not being heard enough. Based on these objections, further specification or modification of reassurance criterion seems to be useful. Fink et al. (14) did not include the reassurance criterion in their new empirically derived set of diagnostic criteria for hypochondriasis any more, because it lacked discrimination between different somatoform disorders.

The present study revealed a very low prevalence of the hypochondriasis (fulfilling all criteria), which is not sufficient evidence to abandon the criterion of reassurance as has been suggested previously (10). However, results showed that already subjects with a syndrome consisting of persistent and interfering hypochondriac illness worry show features that are generally associated with full hypochondriasis. The present study addressed only some relevant external criteria variables such as sociodemographic characteristics, healthcare utilization, and other aspects of illness behavior and health-related quality of life. Further studies on the validity of the diagnostic criteria should consider additional external criteria variables (e.g., cognitive–perceptual and biologic processes), but also predisposing factors and aspects of predictive validity (stability of the syndrome; responsiveness to treatment).

Several authors suggested modifications of the current classification of somatoform disorders: Rief and Hiller (35) proposed three different somatoform diagnostic categories characterized by multiple somatization, specific somatoform symptoms, or health anxiety. Fink et al. (14) suggested a new set of empiric diagnostic criteria for hypochondriasis with obsessive rumination about illness as the central feature. In agreement with these authors, we recommend the adoption of a severity specifier to distinguish clinically relevant subgroups.

Clinical Perspectives
The importance of early intervention in hypochondriasis and somatization has been emphasized because the condition becomes more refractory once the patient develops a stable adaptation of the sick role (4), and there is the risk of iatrogenic harm that can result from somatization (36,37). Chronic somatoform disorders are usually associated not only with substantial individual burden for the patient, but also with high direct healthcare costs (as a result of inappropriate or overutilization of medical services) and high indirect costs (disability and work loss resulting from sickness behavior) (38). A number of interventions have been developed and the effectiveness of cognitive–behavioral therapy has been demonstrated (39–41). Early access to appropriate interventions relies on the early identification of the disorder. This could be facilitated by focusing on central features such as preoccupation with health and illness worry. The present study has provided further evidence on the clinical relevance of hypochondriac conditions, which are still labeled as "subthreshold" by current diagnostic classification systems.


    Appendix 1
 TOP
 ABSTRACT
 INTRODUCTION
 METHOD
 RESULTS
 DISCUSSION
 Appendix 1
 NOTES
 REFERENCES
 


View this table:
[in this window]
[in a new window]
 
APPENDIX Diagnostic Coding Algorithm for Hypochondriac Syndromes

 


    NOTES
 TOP
 ABSTRACT
 INTRODUCTION
 METHOD
 RESULTS
 DISCUSSION
 Appendix 1
 NOTES
 REFERENCES
 
Note: The first author, Dr. Alexandra Martin, previously has published under the name "Nanke."

Data of this study are available as Public Use File from the second author (manual and variable description in German): Dr. Frank Jacobi, Institute of Clinical Psychology and Psychotherapy, Chemnitzer Str. 46, D-01187 Dresden. E-mail: jacobi{at}psychologie.tu-dresden.de. For further information about the Core Survey (GHS-CS) and its public use file, contact the Robert Koch-Institute, Mrs. Ross, Nordufer 20, D-13353 Berlin. E-mail: rossp{at}rki.de

Received for publication September 5, 2005; revision received April 7, 2006.

DOI:10.1097/01.psy.0000238213.04984.b0


    REFERENCES
 TOP
 ABSTRACT
 INTRODUCTION
 METHOD
 RESULTS
 DISCUSSION
 Appendix 1
 NOTES
 REFERENCES
 

  1. ICD-10, The ICD-10 Classification of Mental and Behavioural Disorders, Diagnostic Criteria for Research. Geneva: World Health Organization; 1993.
  2. ICD-10 International Statistical Classification of Diseases and Related Health Problems, Tenth Revision, 2nd ed. Geneva: World Health Organization; 2005.
  3. Noyes R, Kathol RG, Fisher MM, Phillips BM, Suelzer MT, Holt CS. The validity of DSM-III-R hypochondriasis. Arch Gen Psychiatry 1993;50:961–70.[Abstract]
  4. Barsky A, Ettner SL, Horsky J, Bates DW. Resource utilization of patients with hypochondriacal health anxiety and somatization. Med Care 2001;39:705–15.[CrossRef][Medline]
  5. Lieb R, Zimmermann P, Friis RH, Höfler M, Tholen S, Wittchen H-U. The natural course of DSM-IV somatoform disorders and syndromes among adolescents and young adults: a prospective–longitudinal community study. Eur Psychiatry 2002;17:321–31.[CrossRef][Medline]
  6. Looper KJ, Kirmayer LJ. Hypochondriacal concerns in a community population. Psychol Med 2001;31:577–84.[CrossRef][Medline]
  7. Noyes R, Carney CP, Hillis SL, Jones LE, Langbehn DR. Prevalence and correlates of illness worry in the general population. Psychosomatics 2005;46:529–39.[Abstract/Free Full Text]
  8. Noyes R, Hartz AJ, Doebbeling CC, Malis RW, Happel RL, Werner LA, Yangla SJ. Illness fears in the general population. Psychosom Med 2000;62:318–25.[Abstract/Free Full Text]
  9. Rief W, Hessel A, Braehler E. Somatization symptoms and hypochondriacal features in the general population. Psychosom Med 2001;63:595–602.[Abstract/Free Full Text]
  10. Gureje O, Üstün TB, Simon GE. The syndrome of hypochondriasis: a cross-national study in primary care. Psychol Med 1997;27:1001–10.[CrossRef][Medline]
  11. Escobar JI, Gara M, Waitzkin H, Silver RC, Holman A, Compton W. DSM-IV hypochondriasis in primary care. Gen Hosp Psychiatry 1998;20:155–9.[CrossRef][Medline]
  12. Peveler R, Kilkenny L, Kinmonth AL. Medically unexplained physical symptoms in primary care: a comparison of self-report screening questionnaires and clinical opinion. J Psychosom Res 1997;42:245–52.[Medline]
  13. Creed F, Barsky A. A systematic review of the epidemiology of somatisation disorder and hypochondriasis. J Psychosom Res 2004;56:391–408.[CrossRef][Medline]
  14. Fink P, Ornbol E, Toft T, Sparle KC, Frostholm L, Olesen F. A new, empirically established hypochondriasis diagnosis. Am J Psychiatry 2004;161:1680–91.[Abstract/Free Full Text]
  15. Knäuper B, Wittchen H-U. Diagnosing major depression in the elderly: evidence for response bias in standardized diagnostic interviews? J Psychiatr Res 1994;28:147–64.[CrossRef][Medline]
  16. Jacobi F, Wittchen H, Holting C, Sommer S, Lieb R, Höfler M, et al. Estimating the prevalence of mental and somatic disorders in the community: aims and methods of the German National Health Interview and Examination Survey. International Journal of Methods in Psychiatric Research 2002;11:1–18.[CrossRef][Medline]
  17. Stolzenberg H. Bundes-Gesundheitssurvey 1998: Dokumentation des Datensatzes. Berlin: Robert Koch Institut; 2000.
  18. Wittchen HU, Lachner G, Wunderlich U, Pfister H. Test–retest reliability of the computerized DSM-IV version of the Munich-Composite International Diagnostic Interview (M-CIDI). Soc Psychiatry Psychiatr Epidemiol 1998;33:568–78.[CrossRef][Medline]
  19. Composite International Diagnostic Interview (CIDI, Version 2.1). Geneva: World Health Organization; 1997.
  20. Wittchen HU, Essau CA, Rief W, Fichter MM. Assessment of somatoform disorders and comorbidity patterns with the CIDI—findings in psychosomatic inpatients. International Journal of Methods in Psychiatry Research 1993;3:87–99.
  21. Ware JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). Conceptual framework and item selection. Med Care 1992;30:473–83.[Medline]
  22. Bullinger M, Kirchberger I. German translation and psychometric testing of the SF-36 health survey: preliminary results from the IQOLA Project. Soc Sci Med 1995;41:1359–66.[CrossRef][Medline]
  23. Winkler G, Filipiak B, Hense H-W, Schwertner B. Externe Qualitätskontrolle im Bundes-Gesundheitssurvey 1997/1998: Konzepte und erste Erfahrungen. Das Gesundheitswesen 1998;60:108–12.
  24. Stata Statistical Software: Release 7.0. College Station, TX: Stata Corp; 2001.
  25. Welch BL. On the comparison of several mean values: an alternative approach. Biometrika 1951;38:330–6.[Free Full Text]
  26. Howell DC. Statistical Methods for Psychology, 5th ed. Pacific Grove, CA: Duxbury; 2002.
  27. Games PA, Howell JF. Pairwise multiple comparison procedures with unequal N's and/or variances: a Monte Carlo study. Journal of Educational Statistics 1976;1:113–25.[CrossRef]
  28. Games PA, Keselman HJ, Rogan JC. Simultaneous pairwise multiple comparison procedures for means when sample sizes are unequal. Psychol Bull 1981;90:594–8.[CrossRef]
  29. Jacobi F, Wittchen H-U, Hölting C, Höfler M, Pfister H, Müller N, Lieb R. Prevalence, co-morbidity and correlates of mental disorders in the general population: results from the German Health Interview and Examination Survey (GHS). Psychol Med 2004;34:597–611.[CrossRef][Medline]
  30. van Dulmen AM, Fennis JFM, Mokkink HGA, Bleijenberg G. The relationship between complaint-related cognitions in referred patients with irritable bowel syndrome and subsequent health care seeking behaviour in primary care. Fam Pract 1996;13:12–7.[Abstract/Free Full Text]
  31. Hollifield M, Paine S, Tuttle L, Kellner R. Hypochondriasis, somatization, and perceived health and utilization of health care services. Psychosomatics 1999;40:380–6.[Abstract/Free Full Text]
  32. Smith GR, Monson RA, Ray DC. Patients with multiple unexplained symptoms. Their characteristics, functional health, and health care utilization. Arch Intern Med 1986;146:69–72.[Abstract]
  33. Fink P, Sorensen L, Engberg M, Holm M, Munk-Jorgensen P. Somatization in primary care: prevalence, health care utilization, and general practitioner recognition. Psychosomatics 1999;40:330–8.[Abstract/Free Full Text]
  34. Starcevic V. Clinical features and diagnosis of hypochondriasis. In: Starcevic V, Lipsitt DR, eds. Hypochondriasis: Modern Perspectives on an Ancient Malady. Oxford: University Press; 2001:21–60.
  35. Rief W, Hiller W. Toward empirically based criteria for somatoform disorders. J Psychosom Res 1999;46:507–18.[CrossRef][Medline]
  36. Fink P. Surgery and medical treatment in persistent somatizing patients. J Psychosom Res 1992;36:439–47.[CrossRef][Medline]
  37. Kouyanou K, Pither CE, Wessely S. Iatrogenic factors and chronic pain. Psychosom Med 1997;59:597–604.[Abstract]
  38. Hiller W, Fichter M. High utilizer of medical care. A crucial subgroup among somatizing patients. J Psychosom Res 2004;56:437–43.[CrossRef][Medline]
  39. Barsky AJ, Ahern DK. Cognitive behavior therapy for hypochondriasis. A randomized controlled trial. JAMA 2004;291:1464–70.[Abstract/Free Full Text]
  40. Clark DM, Salkovskis PM, Hackman A, Wells A, Fennell M, Ludgate J, Ahmad S, Richards HC, Gelder M. Two psychological treatments for hypochondriasis. Br J Psychiatry 1998;173:218–25.[Abstract/Free Full Text]
  41. Visser S, Bouman TK. The treatment of hypochondriasis: exposure plus response prevention vs cognitive therapy. Behav Res Ther 2001;39:423–42.[CrossRef][Medline]



This article has been cited by other articles:


Home page
Psychosom. Med.Home page
R. Lieb, G. Meinlschmidt, and R. Araya
Epidemiology of the Association Between Somatoform Disorders and Anxiety and Depressive Disorders: An Update
Psychosom Med, November 1, 2007; 69(9): 860 - 863.
[Abstract] [Full Text] [PDF]


Home page
Psychosom. Med.Home page
W. Rief and G. Rojas
Stability of Somatoform Symptoms Implications for Classification
Psychosom Med, November 1, 2007; 69(9): 864 - 869.
[Abstract] [Full Text] [PDF]


Home page
PsychosomaticsHome page
K. Kroenke, M. Sharpe, and R. Sykes
Revising the Classification of Somatoform Disorders: Key Questions and Preliminary Recommendations
Psychosomatics, August 1, 2007; 48(4): 277 - 285.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Martin, A.
Right arrow Articles by Jacobi, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Martin, A.
Right arrow Articles by Jacobi, F.
Related Collections
Right arrow Somatoform
Right arrow Other Psychiatric Disorders


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS